SCHEMBL20129617

SCHEMBL20129617

CC1(C)C(=O)N(Cc2ccc(CO)cc2)CCN1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
POLB P06746 1/20 0.40
CYP2C19 P33261 1/20 0.40
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
OPRL1 P41146 1/20 0.39
GRM4 Q14833 2/20 0.39
ELANE P08246 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP3A4 P08684 1/20 0.37
LMNA P02545 1/20 0.37
BRD4 O60885 1/20 0.37
HSD11B1 P28845 1/20 0.37
BDKRB2 P30411 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133629 0.85 GAA (0.49) KMT2AMEN1OPRM1OPRL1LMNA
SCHEMBL15140135 0.72 AR (0.47)
SCHEMBL20129626 0.71 PRMT5 (0.54) KMT2AMEN1CYP2D6CYP2C9POLB
SCHEMBL20129639 0.71 MAPK1 (0.40) KMT2ACYP2D6CYP2C9POLBCYP2C19
SCHEMBL12451876 0.70 HDAC1 (0.66) KMT2AMEN1CYP2D6CYP2C9POLB
SCHEMBL6341183 0.67 DDB1 (0.55) KMT2AMEN1CYP2D6CYP2C9POLB
SCHEMBL24992399 0.66 KMT2A (0.61) KMT2AMEN1CYP2D6CYP2C9POLB
SCHEMBL4513866 0.66 KDM4E (0.57) KMT2AMEN1CYP2D6CYP2C9POLB
SCHEMBL3194202 0.65 KMT2A (0.55) KMT2AMEN1CYP2D6CYP2C9POLB
SCHEMBL29137409 0.64 KMT2A (0.58) KMT2AMEN1CYP2D6CYP2C9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR KMT2A 1716/4885MEN1 3142/4885CYP2D6 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.